Patents Assigned to Sanofi-Aventis Deutschland Gmb
  • Zinc-free and low-zinc insulin preparations having improved stability
    Patent number: 7205276
    Abstract: The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
    Type: Grant
    Filed: December 9, 2004
    Date of Patent: April 17, 2007
    Assignee: Sanofi-Aventis Deutschland Gmb
    Inventor: Peter Boderke
  • Zinc-free and low-zinc insulin preparations having improved stability
    Patent number: 7205277
    Abstract: The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
    Type: Grant
    Filed: December 9, 2004
    Date of Patent: April 17, 2007
    Assignee: Sanofi-Aventis Deutschland Gmb
    Inventor: Peter Boderke